Corresponding author: Ahmed M. Magdy ( ahmed.m.magdy.ahmed@gmail.com ) Academic editor: Plamen Peikov
© 2021 Ahmed M. Magdy, Mahmoud A. Seksaka, Gehan F. Balata.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
M. Magdy A, A. Seksaka M, F. Balata G (2021) Antibiotic overuse in obstetric and gynecologic procedures at Zagazig university hospitals: A prospective observational study. Pharmacia 68(4): 883-889. https://doi.org/10.3897/pharmacia.68.e71923
|
Surgical site infection (SSI) constitutes a major problem in healthcare in terms of healthcare cost, morbidity and mortality. Surgical antibiotic prophylaxis (SAP) is one of the effective strategies for SSI prevention. Poor adherence to SAP guidelines across different countries has been observed. Misuse of prophylactic antibiotics threatens patient safety and leads to an increase in the acquisition of antibiotic resistance. The aim of this study was to assess the utilization of SAP in obstetric and gynecologic procedures in terms of indication for prophylaxis, antibiotic selection, timing of administration and prophylaxis duration. A prospective observational study was conducted at the obstetrics and gynecology department of Zagazig University Hospital during the period from January 2020 to June 2020. Medical records of 264 women were recorded and evaluated. The American Society of Health-System Pharmacists (ASHP) therapeutic guidelines, World Health Organization (WHO) recommendations and The American College of Obstetricians and Gynecologists (ACOG) practice bulletin were used for data evaluation and hence women were stratified into two groups. For women who underwent procedures in which guidelines recommended the use of SAP (200 patients; 75.75%), 198 women (99%) received preoperative prophylaxis. None of women (0%) received the recommended first line antibiotic by guidelines while the most commonly used prophylactic antibiotics were Cefotaxime (86 patients; 43.43%) and Ampicillin-sulbactam (62 patients; 31.31%). Preoperative antibiotic prophylaxis timing was 0-60 minutes before skin incision. All women received postoperative prophylaxis that extended to an average of 7 days. Regarding the other group who underwent procedures in which prophylactic antibiotics weren’t recommended by guidelines (64 patients; 24.24%), 37 women (57.81%) followed the guidelines and didn’t receive SAP while 27 women (42.18%) received SAP. Poor adherence to guidelines recommendations regarding prophylactic antibiotic selection and prophylaxis duration was observed. High utilization rate of prophylactic antibiotics in procedures that didn’t require their use was reported..
antibiotic prophylaxis, cesarean delivery, surgical site infection
Surgical antibiotic prophylaxis (SAP) is the rational, effective and safe use of antibiotic agents for reducing the risk of surgical site infection (SSI) (
Evaluate the utilization of prophylactic antibiotics in obstetric and gynecologic procedures in terms of: indication for prophylaxis, antibiotic selection, timing of administration and prophylaxis duration.
Set appropriate recommendations to optimize SAP utilization in the future.
Study setting and period
This prospective observational study was conducted at the obstetrics and gynecology department of Zagazig University Hospital during the period from January 2020 to June 2020, Zagazig University Hospital is a large tertiary hospital in Egypt and is the reference hospital to the Sinai and Qana provinces in addition to the populated Sharkia province.
A 6-month observational cross-sectional study was conducted to assess the use of prophylactic antibiotics in obstetric and gynecologic procedures. Patients attending the obstetrics and gynecologic ward during the study period who fulfilled the inclusion criteria were considered as the study population. Using a convenient sampling method, 264 women who underwent obstetric and gynecologic procedures during the study period were included based on the following inclusion criteria; adult patients, prophylactic antibiotic use and clean, clean-contaminated and contaminated procedures. Exclusion criteria included pediatrics (<18 years old), dirty procedures, presence of preoperative infectious disease and therapeutic uses of antibiotics. Assessment of prophylactic antibiotics utilization against the recommendations published by The American Society of Health-System Pharmacists (ASHP) therapeutic guidelines, World Health Organization (WHO) and The American College of Obstetricians and Gynecologists (ACOG) practice bulletin was performed with regard to the indication for prophylaxis, choice of antibiotic, timing of administration and duration of prophylaxis.
Data was collected from medical records of the patients. Data collected included age in years, diagnosis, type of operation, length of hospital stay, names of prophylactic antibiotics, timing of preoperative prophylaxis administration relative to skin incision, duration of prophylaxis and oral antibiotic regimen given after hospital discharge.
Data were collected, entered and analyzed using Microsoft Office Excel 2010.
Ethical approval for the study was obtained from the Institutional Review Board at the faculty of Medicine, Zagazig University (ZU-IRB#:5074-26-12-2019).
Medical records of 264 women admitted to the department of obstetrics and gynecology over a six month period were collected and evaluated. The average age of the study participants was 28.1 years with a standard deviation of 17.88. The average hospitalization period was 1 day. The most common procedures performed were Cesarean Delivery (CD) (161 procedures; 60.98%), Vaginal Delivery (VD) (64 procedures; 24.24%) and Dilation and Curettage (D&C) (33 procedures; 12.5%). Other procedures were Hysterectomy (5 procedures: 1.89%) and Manual Removal of Placenta (1 procedure; 0.37%). Percentage of performed procedures is illustrated in (Figure
Regarding the indication for prophylactic antibiotics, women were stratified into two groups based on recommendations of ASHP, WHO and ACOG guidelines. The first group included 200 women (75.75%) who underwent procedures in which prophylactic antibiotics were recommended by guidelines. The second group included 64 women (24.24%) who underwent procedures in which prophylactic antibiotics weren’t recommended by guidelines. A diagram showing percentage adherence to ASHP, WHO and ACOG guidelines regarding prophylactic antibiotics utilization is illustrated in (Figure
For the first group in which guidelines recommended use of prophylactic antibiotics according to ASHP, WHO, ACOG Guidelines: 198 women (99%) received preoperative prophylaxis in which 150 patients (75.75%) received a single prophylactic antibiotic, 46 patients (23.23%) received a combination of two prophylactic antibiotics and 2 patients (1.01%) received a combination of three prophylactic antibiotics. Percentage stratification of women in this group according to the number of administered antibiotics for prophylaxis is illustrated in (Figure
Regarding the antibiotic selection, none of women (0%) received the recommended first line antibiotic (Cefazolin) for CD and hysterectomy, (Doxycycline) for D&C or (1st generation cephalosporins or ampicillin) for manual removal of placenta while the most commonly used prophylactic antibiotics were Cefotaxime (86 patients; 43.43%) and Ampicillin-sulbactam (62 patients; 31.31%). Percentage stratification of women in this group according to the prophylactic antibiotics selected is presented in (Table
Percentage stratification of women underwent procedures in which guidelines recommended use of SAP according to the prophylactic antibiotics selected.
Antibiotics used | No of cases | Percentage |
Cefotaxime | 86 | 43.43% |
Ampicillin-sulbactam | 62 | 31.31% |
combination of Cefotaxime and Metronidazole | 21 | 10.6% |
combination of Ampicillin-sulbactam and Metronidazole | 17 | 8.58% |
combination of Cefotaxime and Gentamicin | 6 | 3.03% |
Gentamicin | 2 | 1.01% |
combination of Ampicillin-sulbactam and Gentamicin | 1 | 0.5% |
combination of Cefotaxime, Metronidazole and Gentamicin | 1 | 0.5% |
combination of Cefotaxime and Ampicillin-sulbactam | 1 | 0.5% |
combination of Ampicillin-sulbactam, Cefotaxime and Metronidazole | 1 | 0.5% |
Regarding timing of prophylaxis administration, preoperative antibiotic prophylaxis timing for all women was 0-60 minutes before skin incision and this was consistent with recommendations of ASHP, WHO, ACOG guidelines. This finding is comparable with a study in India reported that timing of prophylaxis administration was appropriate in 89% of cases (
Regarding duration of prophylaxis, postoperatively; all patients (100%) received additional antibiotic prophylaxis as following; 179 patients (89.5 %) received a combination of three antibiotics, 20 patients (10%) received a combination of two antibiotics and one patient (0.5%) received a single antibiotic. Percentage stratification of women in this group according to the number of postoperative antibiotics used is presented in (Figure
Percentage stratification of women underwent procedures in which guidelines recommended use of SAP according to the postoperative prophylactic antibiotics selected.
Antibiotic | No of cases | Percentage |
Combination of Ampicillin-sulbactam, Cefotaxime and Metronidazole | 33 | 51.56% |
Combination of Ampicillin-sulbactam and Metronidazole | 12 | 18.75% |
Combination of Cefotaxime and Metronidazole | 8 | 12.50% |
Combination of Cefotaxime, Metronidazole and Gentamicin | 5 | 7.81% |
Combination of Ampicillin-sulbactam, Gentamicin and Metronidazole | 2 | 3.12% |
Combination of Amoxicillin and Flucloxacillin | 2 | 3.12% |
Combination of Cefotaxime and Ampicillin-sulbactam | 1 | 1.56% |
Combination of Cefotaxime and Gentamicin | 1 | 1.56% |
For the second group who underwent procedures in which prophylactic antibiotics weren’t recommended by guidelines: 37 patients (57.81%) followed the guidelines and didn’t receive SAP while 27 women (42.18%) received SAP. Percentage of preoperative antibiotics prescription in this group is illustrated in (Figure
Percentage stratification of women underwent procedures in which guidelines didn’t recommend use of SAP according to the preoperative prophylactic antibiotics selected.
Antibiotic | No of cases | Percentage |
Cefotaxime | 14 | 51.85% |
Ampicillin-sulbactam | 10 | 37.03% |
Combination of Ampicillin-sulbactam and Metronidazole | 2 | 7.4% |
Combination of Cefotaxime and Metronidazole | 1 | 3.7% |
Among the causes of non-adherence to SAP guidelines are the false generalization that using broad spectrum or combined prophylactic antibiotics and prolonged duration of prophylaxis are more effective in preventing SSIs and complications postoperatively than using narrow spectrum prophylactic antibiotics for short duration, easy accessibility to many antibiotics that weren’t mentioned in guidelines and unawareness of SAP guidelines (
This study encountered some limitations as most of the data were obtained from medical records so the data accuracy depended on the quality of recording system and some baseline characteristics of women weren’t reported such as body mass index, medications (like immunosuppressant drugs, steroids), comorbidities (like obesity, diabetes) and nutritional status due to lacking of these data from medical records, these factors could affect decision making regarding regimen of antibiotic prophylaxis as they may increase the risk of infection. This study is a mono-center study with a relatively small sample size so this would restrict generalization of the study findings to other areas.
The selection of prophylactic antibiotics and the duration of prophylaxis were inconsistent with the recommendations of ASHP, WHO and ACOG guidelines. The use of broad spectrum prophylactic antibiotics and multidrug regimen were common practices identified in this study. This study reported a high rate of prophylactic antibiotics utilization in procedures that didn’t require their uses. There is an urgent need for implementation of an antimicrobial stewardship program to optimize antibiotics use, reduce risk of resistance, improve clinical outcomes and reduce the cost of health care service. Moreover, there is an urgent need for establishment of an infection control committee to ensure implementation of infection control policies. Pharmacists must be given a central role in the selection, administration, monitoring of prophylactic antibiotics. Clinical pharmacist must promote optimal use of SAP by establishing and implementation of evidence based SAP guidelines for local setting based on international recommendations, monitor adherence to SAP guideline, ensure availability of the recommended first line prophylactic antibiotics and spread awareness among healthcare professionals about benefits of rational use of SAP through newsletters, clinical conferences and other types of educational tools. Future research is needed for performing outcomes based assessment of prophylactic antibiotics utilization after implementation of an antimicrobial stewardship program.